Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Loperamide products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An antidiarrheal used to relieve acute and chronic diarrhea.
Products affected
1 / 5
In shortage since
Oct 9, 2014
Reports on file
12
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-LOPERAMIDE - TAB 2MG
2MG · TABLET · APOTEX INC
DIN 02212005 · since Oct 9, 2014, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended Jul 20, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended Sep 30, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended Jul 22, 2020 · Disruption of the manufacture of the drug.
Resolved
PMS-LOPERAMIDE - CAPLET 2MG
2MG · TABLET · PHARMASCIENCE INC
DIN 02228351 · ended Feb 6, 2019 · Disruption of the manufacture of the drug.
Resolved
PMS-LOPERAMIDE - CAPLET 2MG
2MG · TABLET · PHARMASCIENCE INC
DIN 02228351 · ended Jan 16, 2019 · Disruption of the manufacture of the drug.
Resolved
LOPERAMIDE-2
2MG · TABLET · PRO DOC LIMITEE
DIN 02225182 · ended Dec 5, 2018 · Delay in shipping of the drug.
Resolved
TEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended May 10, 2018 · Disruption of the manufacture of the drug.
Resolved
TEVA-LOPERAMIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02132591 · ended May 10, 2018 · Disruption of the manufacture of the drug.
Resolved
PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML
0.2MG · SOLUTION · PHARMASCIENCE INC
DIN 02016095 · ended Feb 8, 2018 · Disruption of the manufacture of the drug.
Avoided
PMS-LOPERAMIDE - CAPLET 2MG
2MG · TABLET · PHARMASCIENCE INC
DIN 02228351 · ended May 10, 2017 · Disruption of the manufacture of the drug.
Discontinued
APO-LOPERAMIDE - TAB 2MG
2MG · TABLET · APOTEX INC
DIN 02212005
What's happening
Loperamide is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Loperamide is classified under “ANTIPROPULSIVES” (ATC A07DA).
Recent changes
No changes recorded yet.
Common questions
What is Loperamide used for?
An antidiarrheal used to relieve acute and chronic diarrhea.
When will Loperamide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Loperamide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.